US5008185A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methods and apparatus for the quantitation of nuclear proteins
Assignee: Cell Analysis Systems Inc
•
Filing: 1987-10-06
•
Granted: 1991-04-16
•
Expires: 2007-10-06
Abstract
Abstract An image analysis system is used for the quantitation of nuclear proteins in cell populations. Particularly, the hormonal receptor content of fine needle aspirates of human breast carcinomas are evaluated. Estrogen or progesterone receptors are amplified and visualized in the specimen by a staining technique of the immunoperoxidase type. Monoclonal antibodies specific against the receptor are attached to the receptor sites and are then amplified by a bridging antibody which attaches to the monoclonal antibody and a peroxidase-antiperoxidase complex. A chromagen, diaminobenzidine is combined with the complex and treated with hydrogen peroxide to react with the peroxidase forming an insoluble brown precipitate which marks the receptor sites for optical identification. The specimen is then counterstained with another chromagen, methyl green which is specific to the nucleus of each cell. Two monochromatic filterings optionally separate the areas stained by the receptor site optical enhancer and the nuclear area optical enhancer. Measurements of the optical density values of the stained receptor areas yield an intensity value directly related to the quantity of hormonal receptor in the specimen. A comparison of the nuclear area containing hormonal receptor with the total nuclear area yields a percentage value which indicates the distribution of cells throughout of the specimen which contain receptor. These two values for intensity and distribution are then combined to yield a predictive score for an assay. The measured score when compared to an empirically derived reference score is predictive of the prognosis of endocrine therapy.
Inventors
- 👤 James W. Bacus
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 11:12
CPC Classifications
G; G01; G01N; G01N15/00; G01N15/10; G01N15/14; G01N15/1429; G01N15/1433; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/575; G01N33/57515; G01N33/57575; G01N33/68; G01N33/74; G01N33/743; G06; G06V; G06V20/00; G06V20/60; G06V20/69; G01N1/00; G01N1/28; G01N1/30; G01N21/00; G01N21/62; G01N21/63; G01N21/64; G01N21/645; G01N21/6456; G01N21/6458; G01N2201/00; G01N2201/12; G01N2201/127; G01N2474/00; G01N2474/20; Y; Y10; Y10S; Y10S435/00; Y10S435/808; Y10S436/00; Y10S436/805; Y10S436/807; Y10S436/811; Y10S436/813; Y10S436/815; Y10S436/817
Claims Analysis
Total Claims: 37
Claim 1
Independent Claim
148 words
A method for measuring a nuclear antigen in a tissue sample containing cells with an immunohistochemical technique using an antibody to said nuclear antigen and a microscopic digital image measuring means, said method comprising the steps of: staining the sample with an immunohistochemical technique to optically enhance and to stain nuclear antigens with a first spectral stain material which varies with the quantity of the nuclear antigen contained in the sample, optically enhancing the sample with a second spectral stain material which optically enhances nuclear material in the cells, measuring the optically-enhanced nuclear material with a microscopic digital image measuring means at a first wavelength range which allows identification of all of the enhanced nuclear material, measuring the optically-enhanced antigen with the microscopic digital image measuring means at a second wavelength range which substantially excludes the optically-enhanced nuclear material, and quantitating the nuclear antigen using the measurements made.
Claim 2
Independent Claim
148 words
A method for measuring a nuclear antigen in a tissue sample containing cells with an immunohistochemical technique using an antibody to said nuclear antigen and a microscopic digital image measuring means, said method comprising the steps of: staining the sample with an immunohistochemical technique to optically enhance and to stain nuclear antigens with a first spectral stain material which varies with the quantity of the nuclear antigen contained in the sample, optically enhancing the sample with a second spectral stain material which optically enhances nuclear material in the cells, measuring the optically-enhanced nuclear material with a microscopic digital image measuring means at a first wavelength range which allows identification of all of the enhanced nuclear material, measuring the optically-enhanced antigen with the microscopic digital image measuring means at a second wavelength range which substantially excludes the optically-enhanced nuclear material, and quantitating the nuclear antigen using the measurements made.
Claim 3
Dependent Claim
64 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 1 wherein the step of staining further includes: staining said sample with peroxidase-antiperoxidase complex and a monoclonal antibody to estrogen receptors thereby producing different quantities of a precipitate of diaminobenzidine having varying optical densities in dependence on the amount of estrogen receptor in the nuclear material in said sample.
Claim 4
Dependent Claim
47 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 2 wherein said step of staining the sample further includes a second stain step of counterstaining said sample with a second image enhancement factor which enhances all nuclear material of said sample.
Claim 5
Dependent Claim
28 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 3 wherein said step of counterstaining includes: staining said sample with methyl green.
Claim 6
Dependent Claim
64 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 3 wherein said step of measuring the nuclear material further includes: measuring all nuclear material in said sample by filtering an image of said sample with a first filter to produce an enhanced first filtered image which only represents the area of the total nuclear material of said sample.
Claim 7
Dependent Claim
56 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 5 wherein said step of measuring for the nuclear antigen further includes: filtering the image of said sample with a second filter to produce an enhanced second filtered image of nuclear antigen areas of said total nuclear area which are stained.
Claim 8
Dependent Claim
54 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 6 wherein said step of filtering the image of said sample includes: filtering the image of said sample with said first filter having a bandpass to light substantially in the 620 nanometer range to provide a first filtered image.
Claim 9
Dependent Claim
54 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 7 wherein said step of filtering the image of said sample includes: filtering the image of said sample with said second filter having a bandpass to light substantially in the 500 nanometer range to provide a second filtered image.
Claim 10
Dependent Claim
53 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 8 wherein said step of filtering includes: combining said enhanced first filtered image with said enhanced second filtered image to exclude image areas not included in both said enhanced first filtered image and said enhanced second filtered image.
Claim 11
Dependent Claim
54 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 8 wherein said step of filtering includes: combining said enhanced first filtered image with said enhanced second filtered image to exclude image areas of said enhanced second filtered image which are not included in said enhanced first filtered image.
Claim 12
Dependent Claim
62 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 5 wherein said step of filtering the image of said sample with a first filter further includes: comparing the first filtered image with a first threshold optical density and setting areas in said image with an optical density below said first threshold to a background optical density.
Claim 13
Dependent Claim
45 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 11 wherein said step of measuring optical density includes: determining a first area of said enhanced first filtered image which has an optical density in excess of said first threshold.
Claim 14
Dependent Claim
62 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 6 wherein said step of filtering the image of said sample with a second filter further includes: comparing said second filtered image with a threshold optical density and setting areas in said image with an optical density below said threshold optical density to a background optical density.
Claim 15
Dependent Claim
44 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 13 wherein said step of measuring optical density includes: determining an area of said second filtered image which has an optical density in excess of said threshold optical density.
Claim 16
Dependent Claim
37 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 14 wherein said step of measuring optical density further includes: determining the proportion that said second area is of said first area.
Claim 17
Dependent Claim
42 words
A method for measuring the quantity of a nuclear antigen as set forth in claim 15 wherein said step of determining a second area includes: calculating said threshold optical density from a control sample which is similarly stained as said first-mentioned sample.
Claim 18
Dependent Claim
53 words
A method in accordance with claim 1 including the further steps of: forming separate optically-enhanced images of the nuclear antigen and the nuclear material and then electronically combining these separate images and presenting them to a user for viewing as a combined image showing both the image-enhanced nuclear antigen and the nuclear material.
Claim 19
Dependent Claim
38 words
A method in accordance with claim 1 in which step of quantitating comprises counting the cells and counting as positive those cells which exhibit the antigen and reporting the percentage of positive cells of the total cells counted.
Claim 20
Dependent Claim
44 words
A method in accordance with claim 1 including the steps of measuring the first optically-enhanced nuclear antigen at a bandwidth wavelength range at which the first spectral stain material has a substantial transmittance and at which the second spectral stain material is substantially nontransmissive.
Claim 21
Dependent Claim
34 words
A method in accordance with claim 19 in which the step of measuring the optical density of the optically-enhanced image includes measuring at a bandwidth at which the spectral stain has approximately 100% transmittance.
Claim 22
Dependent Claim
36 words
A method in accordance with claim 19 wherein the nuclear antigen and nuclear material are stained with two different spectral materials and measuring one of the spectral materials where the other materials has the greatest transmission.
Claim 23
Independent Claim
136 words
A method of providing a quantitative immunocytochemical measurement of a nuclear antigen in a carcinoma, said method comprising the steps of: providing a tissue specimen having a cell population of the carcinoma; staining said cell population with an immunological first stain which specifically identifies an antigen in the cell's nucleus; measuring the percentage of the cell population stained with said first stain and with a microscopic digital image measuring means at a first wavelength; staining said cell population with a counterstain which enhances all nuclear material of said sample; measuring the intensity of said counterstain applied to the cell population with the microscopic digital image measuring means at a second wavelength; and forming a quantitative immunocytochemical measurement utilizing both the percentage of the cell population stained and the intensity of the stain for the cell population.
Claim 24
Independent Claim
136 words
A method of providing a quantitative immunocytochemical measurement of a nuclear antigen in a carcinoma, said method comprising the steps of: providing a tissue specimen having a cell population of the carcinoma; staining said cell population with an immunological first stain which specifically identifies an antigen in the cell's nucleus; measuring the percentage of the cell population stained with said first stain and with a microscopic digital image measuring means at a first wavelength; staining said cell population with a counterstain which enhances all nuclear material of said sample; measuring the intensity of said counterstain applied to the cell population with the microscopic digital image measuring means at a second wavelength; and forming a quantitative immunocytochemical measurement utilizing both the percentage of the cell population stained and the intensity of the stain for the cell population.
Claim 25
Dependent Claim
37 words
A method as set forth in claim 22 wherein said step of staining includes: staining said cell population with a peroxidase-antiperoxidase complex and including a monoclonal antibody against estrophilin; and counterstaining said cell population with methyl green.
Claim 26
Dependent Claim
36 words
A method as set forth in claim 22 wherein said step of measuring stain intensity includes: measuring the optical density of the area stained with a primary stain which is in excess of a threshold value.
Claim 27
Dependent Claim
59 words
A method as set forth in claim 22 wherein said step of measuring the percentage of a cell population stained includes: measuring the total nuclear area of said cell population; measuring the nuclear area of said cell population stained with a primary stain; and calculating the percentage that said primary stained nuclear area is of said total nuclear area.
Claim 28
Independent Claim
187 words
A method of analysis of estrogen or progesterone receptors in tumors in a human breast carcinoma, said method including the steps of: staining cells in a carcinoma cell population by an immunocytochemical technique to optically enhance and to specifically identify the nuclear antigens estrophilin or progesterone with a first spectral stain material which varies with the quantity of said nuclear antigen, optically enhancing the sample with a second spectral stain material which optically enhances nuclear material in the cells, measuring the optically-enhanced nuclear material with a digital image measuring means at a first wavelength range which allows identification of all of the enhanced nuclear material, measuring the optically-enhanced antigen with the microscopic digital image measuring means at a second wavelength range which substantially excludes the optically-enhanced nuclear material, and quantitating the estrophilin or progesterone antigen using the measurements made, providing a predetermined value above which tumors are classified as an estrogen or progesterone receptor rich tumor and below which tumors are classified as an estrogen or progesterone receptor poor tumor; and reporting a quantitative analysis based on measured value relative to the predetermined value for the tumors.
Claim 29
Independent Claim
187 words
A method of analysis of estrogen or progesterone receptors in tumors in a human breast carcinoma, said method including the steps of: staining cells in a carcinoma cell population by an immunocytochemical technique to optically enhance and to specifically identify the nuclear antigens estrophilin or progesterone with a first spectral stain material which varies with the quantity of said nuclear antigen, optically enhancing the sample with a second spectral stain material which optically enhances nuclear material in the cells, measuring the optically-enhanced nuclear material with a digital image measuring means at a first wavelength range which allows identification of all of the enhanced nuclear material, measuring the optically-enhanced antigen with the microscopic digital image measuring means at a second wavelength range which substantially excludes the optically-enhanced nuclear material, and quantitating the estrophilin or progesterone antigen using the measurements made, providing a predetermined value above which tumors are classified as an estrogen or progesterone receptor rich tumor and below which tumors are classified as an estrogen or progesterone receptor poor tumor; and reporting a quantitative analysis based on measured value relative to the predetermined value for the tumors.
Claim 30
Independent Claim
166 words
A method for measuring the quantity of a specific nuclear antigen in a cell population taken from a human breast carcinoma with a microscopic digital image measuring means, said method comprising: obtaining a cell population sample from a human breast carcinoma; staining said sample with an immunohistochemical technique using an antibody against the specific nuclear antigen, said immunohistochemical technique including an image enhancement factor such that the optical density of said sample varies with the quantity of nuclear antigen contained within said sample; staining said sample with at least one other image enhancement factor which is specific for the nucleus of the cells in said sample; measuring the optical density of the nuclear antigen in said sample with the microscopic digital image measuring means; differentiating the nuclear area of the specific nuclear antigen stained with said optical enhancement factor and measuring these differentiated stained areas with the microscopic digital image measuring means; and determining what percentage the stained nuclear antigen is of the total nuclear area.
Claim 31
Independent Claim
166 words
A method for measuring the quantity of a specific nuclear antigen in a cell population taken from a human breast carcinoma with a microscopic digital image measuring means, said method comprising: obtaining a cell population sample from a human breast carcinoma; staining said sample with an immunohistochemical technique using an antibody against the specific nuclear antigen, said immunohistochemical technique including an image enhancement factor such that the optical density of said sample varies with the quantity of nuclear antigen contained within said sample; staining said sample with at least one other image enhancement factor which is specific for the nucleus of the cells in said sample; measuring the optical density of the nuclear antigen in said sample with the microscopic digital image measuring means; differentiating the nuclear area of the specific nuclear antigen stained with said optical enhancement factor and measuring these differentiated stained areas with the microscopic digital image measuring means; and determining what percentage the stained nuclear antigen is of the total nuclear area.
Claim 32
Dependent Claim
24 words
A method for measuring the quantity of a specific nuclear antigen as set forth in claim 22 wherein: the specific protein is estrogen receptor.
Claim 33
Dependent Claim
27 words
A method for measuring the quantity of a specific nuclear antigen as set forth in claim 29 wherein: said monoclonal antibody is H222 sP2 or H226 sP2.
Claim 34
Dependent Claim
25 words
A method for measuring the quantity of a specific nuclear antigen as set forth in claim 28 wherein: the specific nuclear antigen is progesterone receptor.
Claim 35
Dependent Claim
23 words
A method for measuring the quantity of a specific nuclear antigen as set forth in claim 31 wherein: said monoclonal antibody is mPRI.
Claim 36
Independent Claim
157 words
A method for measuring the distribution of a specific nuclear antigen in a tissue sample with a microscopic digital image measuring means, said method comprising: obtaining a tissue sample from a carcinoma; staining said sample with an immunohistochemical technique using an antibody against the specific nuclear antigen, said immunohistochemical technique including an image enhancement factor such that the optical density of said sample varies with the quantity of nuclear antigen contained within said sample; staining said sample with at least one other image enhancement factor which is specific for the nucleus of the cells in said sample; measuring the optical density of the nuclear antigen in said sample with the microscopic digital image measuring means; separating the nuclear area of the specific nuclear antigen stained with said optical enhancement factor and measuring these separated stained areas with the microscopic digital image measuring means; and determining what percentage the stained nuclear antigen is of the total nuclear area.
Claim 37
Independent Claim
157 words
A method for measuring the distribution of a specific nuclear antigen in a tissue sample with a microscopic digital image measuring means, said method comprising: obtaining a tissue sample from a carcinoma; staining said sample with an immunohistochemical technique using an antibody against the specific nuclear antigen, said immunohistochemical technique including an image enhancement factor such that the optical density of said sample varies with the quantity of nuclear antigen contained within said sample; staining said sample with at least one other image enhancement factor which is specific for the nucleus of the cells in said sample; measuring the optical density of the nuclear antigen in said sample with the microscopic digital image measuring means; separating the nuclear area of the specific nuclear antigen stained with said optical enhancement factor and measuring these separated stained areas with the microscopic digital image measuring means; and determining what percentage the stained nuclear antigen is of the total nuclear area.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-04-15 | 1994-10-15 | 1995-04-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-04-15 | 1998-10-15 | 1999-04-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-04-15 | 2002-10-15 | 2003-04-16 | $7700.00 | Window Closed / Lapsed |